Key points are not available for this paper at this time.
Eneboparatide, a long-acting modified form of parathyroid hormone, increases serum calcium levels without increasing urine calcium in mice with autosomal dominant hypocalcemia type 1.
Hannan et al. (Thu,) studied this question.